• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CGP
Click for more information
6.78% 6.3¢

CONSEGNA GROUP LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
CGPAppendix 4C - quarterlyPRICE SENSITIVE29/10/13
CGPKey European Patent for Breathassist Platform GrantedPRICE SENSITIVE14/10/13
CGP +Shareholder UpdatePRICE SENSITIVE19/09/13
CGPPreliminary Final ReportPRICE SENSITIVE28/08/13
CGPConsegna Raises $1 million via Private PlacementPRICE SENSITIVE21/08/13
CGPTrading HaltPRICE SENSITIVE19/08/13
CGPAppendix 4C - quarterlyPRICE SENSITIVE31/07/13
CGPGlobal Manufacturing Partner for Turbine Nasal DilatorPRICE SENSITIVE30/07/13
CGPPrice Query and ResponsePRICE SENSITIVE05/07/13
CGPResults from BreatheAssist Elite Athletes User TrialPRICE SENSITIVE05/06/13
CGPConsegna advances commercialisation of BreatheAssist SportPRICE SENSITIVE06/05/13
CGPQuarterly Cash Flow & Operations ReportPRICE SENSITIVE30/04/13
CGPConsegna R&D rebate of approximately $510,000PRICE SENSITIVE24/04/13
CGPProspectus for Options Rights IssuePRICE SENSITIVE18/04/13
CGPUpdate on Options Rights IssuePRICE SENSITIVE20/03/13
CGPPrice Query and ResponsePRICE SENSITIVE14/03/13
CGPOptions Rights IssuePRICE SENSITIVE12/03/13
CGPHalf Yearly Report and AccountsPRICE SENSITIVE28/02/13
CGPManagement and Board Changes at Consegna GroupPRICE SENSITIVE01/02/13
CGPAppendix 4C - quarterlyPRICE SENSITIVE31/01/13
CGPTrading HaltPRICE SENSITIVE31/01/13
CGPConsegna strengthens BreatheAssist IP portfolioPRICE SENSITIVE22/01/13
CGPPrivate Placement/SPPPRICE SENSITIVE17/12/12
CGPReinstatementPRICE SENSITIVE17/12/12
CGPSuspension from Official QuotationPRICE SENSITIVE12/12/12
CGPTrading HaltPRICE SENSITIVE10/12/12
CGPBreatheAssist licensing deal negotiations updatePRICE SENSITIVE30/11/12
CGPReply to ASX Query - 4CPRICE SENSITIVE23/11/12
CGP +Consegna Elects to return Aspen MedisysPRICE SENSITIVE01/11/12
CGPAppendix 4C - quarterlyPRICE SENSITIVE31/10/12
CGPBreatheAssist Due Diligence CompletePRICE SENSITIVE03/10/12
CGPBreatheAssist Elite Sports Study ResultsPRICE SENSITIVE25/09/12
CGPPreliminary Final ReportPRICE SENSITIVE31/08/12
CGPPreparations advance for BreatheAssist Elite Sports launchPRICE SENSITIVE17/08/12
CGPConsegna signs LOI for global distribution of BreatheAssistPRICE SENSITIVE16/07/12
CGPTrading HaltPRICE SENSITIVE12/07/12
CGPMajor Development in Aspen Medisys AssetPRICE SENSITIVE04/07/12
CGPRevolutionary BreatheAssist Elite Sports ProductPRICE SENSITIVE03/07/12
CGP +Agreement reached with Imugene for sale of Linguet IPPRICE SENSITIVE01/05/12
CGP +Acquisition of Drug Delivery Platform and Share PlacementPRICE SENSITIVE01/05/12
CGPTrading HaltPRICE SENSITIVE30/04/12
CGPAppendix 4C - quarterlyPRICE SENSITIVE30/04/12
CGPTermination of Call Option on Linguet IPPRICE SENSITIVE27/04/12
CGPBreatheAssist Sport Regulatory UpdatePRICE SENSITIVE19/04/12
CGPAcquisition of the remaining 19% of Leading Edge InstrumentsPRICE SENSITIVE16/04/12
CGPIPO FOR ASPEN MEDISYSPRICE SENSITIVE12/04/12
CGPHalf Yearly Report and AccountsPRICE SENSITIVE01/03/12
CGPAppendix 4C - quarterlyPRICE SENSITIVE31/01/12
CGPReinstatement to Official QuotationPRICE SENSITIVE27/01/12
CGPPrivate PlacementPRICE SENSITIVE27/01/12
CGPSuspension from Official QuotationPRICE SENSITIVE25/01/12
CGPTrading HaltPRICE SENSITIVE23/01/12
CGPConsegna Positioned for GrowthPRICE SENSITIVE20/01/12
CGPResponse to ASX QueryPRICE SENSITIVE05/01/12
CGPCompletion of Private PlacementPRICE SENSITIVE19/12/11
CGPTrading HaltPRICE SENSITIVE15/12/11
CGPBreatheAssist Device Ready for Sports MarketPRICE SENSITIVE29/11/11
CGPAppendix 4C - quarterly
29/10/13PRICE SENSITIVE
CGPKey European Patent for Breathassist Platform Granted
14/10/13PRICE SENSITIVE
CGP +Shareholder Update
19/09/13PRICE SENSITIVE
CGPPreliminary Final Report
28/08/13PRICE SENSITIVE
CGPConsegna Raises $1 million via Private Placement
21/08/13PRICE SENSITIVE
CGPTrading Halt
19/08/13PRICE SENSITIVE
CGPAppendix 4C - quarterly
31/07/13PRICE SENSITIVE
CGPGlobal Manufacturing Partner for Turbine Nasal Dilator
30/07/13PRICE SENSITIVE
CGPPrice Query and Response
05/07/13PRICE SENSITIVE
CGPResults from BreatheAssist Elite Athletes User Trial
05/06/13PRICE SENSITIVE
CGPConsegna advances commercialisation of BreatheAssist Sport
06/05/13PRICE SENSITIVE
CGPQuarterly Cash Flow & Operations Report
30/04/13PRICE SENSITIVE
CGPConsegna R&D rebate of approximately $510,000
24/04/13PRICE SENSITIVE
CGPProspectus for Options Rights Issue
18/04/13PRICE SENSITIVE
CGPUpdate on Options Rights Issue
20/03/13PRICE SENSITIVE
CGPPrice Query and Response
14/03/13PRICE SENSITIVE
CGPOptions Rights Issue
12/03/13PRICE SENSITIVE
CGPHalf Yearly Report and Accounts
28/02/13PRICE SENSITIVE
CGPManagement and Board Changes at Consegna Group
01/02/13PRICE SENSITIVE
CGPAppendix 4C - quarterly
31/01/13PRICE SENSITIVE
CGPTrading Halt
31/01/13PRICE SENSITIVE
CGPConsegna strengthens BreatheAssist IP portfolio
22/01/13PRICE SENSITIVE
CGPPrivate Placement/SPP
17/12/12PRICE SENSITIVE
CGPReinstatement
17/12/12PRICE SENSITIVE
CGPSuspension from Official Quotation
12/12/12PRICE SENSITIVE
CGPTrading Halt
10/12/12PRICE SENSITIVE
CGPBreatheAssist licensing deal negotiations update
30/11/12PRICE SENSITIVE
CGPReply to ASX Query - 4C
23/11/12PRICE SENSITIVE
CGP +Consegna Elects to return Aspen Medisys
01/11/12PRICE SENSITIVE
CGPAppendix 4C - quarterly
31/10/12PRICE SENSITIVE
CGPBreatheAssist Due Diligence Complete
03/10/12PRICE SENSITIVE
CGPBreatheAssist Elite Sports Study Results
25/09/12PRICE SENSITIVE
CGPPreliminary Final Report
31/08/12PRICE SENSITIVE
CGPPreparations advance for BreatheAssist Elite Sports launch
17/08/12PRICE SENSITIVE
CGPConsegna signs LOI for global distribution of BreatheAssist
16/07/12PRICE SENSITIVE
CGPTrading Halt
12/07/12PRICE SENSITIVE
CGPMajor Development in Aspen Medisys Asset
04/07/12PRICE SENSITIVE
CGPRevolutionary BreatheAssist Elite Sports Product
03/07/12PRICE SENSITIVE
CGP +Agreement reached with Imugene for sale of Linguet IP
01/05/12PRICE SENSITIVE
CGP +Acquisition of Drug Delivery Platform and Share Placement
01/05/12PRICE SENSITIVE
CGPTrading Halt
30/04/12PRICE SENSITIVE
CGPAppendix 4C - quarterly
30/04/12PRICE SENSITIVE
CGPTermination of Call Option on Linguet IP
27/04/12PRICE SENSITIVE
CGPBreatheAssist Sport Regulatory Update
19/04/12PRICE SENSITIVE
CGPAcquisition of the remaining 19% of Leading Edge Instruments
16/04/12PRICE SENSITIVE
CGPIPO FOR ASPEN MEDISYS
12/04/12PRICE SENSITIVE
CGPHalf Yearly Report and Accounts
01/03/12PRICE SENSITIVE
CGPAppendix 4C - quarterly
31/01/12PRICE SENSITIVE
CGPReinstatement to Official Quotation
27/01/12PRICE SENSITIVE
CGPPrivate Placement
27/01/12PRICE SENSITIVE
CGPSuspension from Official Quotation
25/01/12PRICE SENSITIVE
CGPTrading Halt
23/01/12PRICE SENSITIVE
CGPConsegna Positioned for Growth
20/01/12PRICE SENSITIVE
CGPResponse to ASX Query
05/01/12PRICE SENSITIVE
CGPCompletion of Private Placement
19/12/11PRICE SENSITIVE
CGPTrading Halt
15/12/11PRICE SENSITIVE
CGPBreatheAssist Device Ready for Sports Market
29/11/11PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
Resolute shares bounce back as second payment made to Mali government to secure workers' release Resolute Mining Ltd has told investors that a second payment has been made to the Mali government following the detention of three employees
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Parkes Au-Cu project to 'transform' Adavale Resources with key targets Adavale Resources Ltd has entered into an all-scrip acquisition of the Parkes gold and copper project in New South Wales
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.